Abstract：Objective To investigate the effectiveness of postoperative radiotherapy using shrinking field for patients with extremity soft tissue sarcoma (STS), mainly focusing on the local control rate and adverse events. Methods Clinical data of 49 extremity STS patients who received postoperative intensity-modulated radiotherapy in the First Hospital of Tsinghua University from October 2017 to March 2021 were retrospectively analyzed. Target volumes were contoured on CT and MRI fusion images. The tumor bed was defined as GTVtb, with 3 cm expansion in the longitudinal direction and 1.5 cm expansion in the radial direction to construct CTV (the target volume should be properly repaired according to the anatomical barrier, and the edema area around the tumor should be included). GTVtb and CTV were expanded in all directions by 0.5 cm to construct PTV1 and PTV2 respectively, at a dose of 95%PTV1 63-66 Gy, 95%PTV2 50-56 Gy,1.8-2.0 Gy/f. The dose of surgical volume should be given at 70 Gy for patients who had a microscopic positive margin. Results The median follow-up time was 32.1 months (7.9-45.6 months). The 3-year local failure-free survival (LFFS), overall survival (OS)and distant metastasis-free survival (DMFS) were 91.7%,77.6% and 71.5%, respectively. Univariate analysis showed that patients with a microscopic positive margin were more likely to develop local recurrence (P<0.05). The incidence of grade 2 or above wound complications, joint stiffness, fracture, edema and skin fibrosis were 2%, 4.1%, 2%, 8.2% and 26.5%, respectively. Conclusions Postoperative radiotherapy with shrinking field provides excellent local control rate and low incidence of late adverse events in patients with extremity STS.
Chen Changshun,Yang Rui,Li Dongbo et al. Clinical efficacy of postoperative radiotherapy using shrinking field for patients with extremity soft tissue sarcoma[J]. Chinese Journal of Radiation Oncology, 2022, 31(7): 617-621.
[1] Gamboa AC, Gronchi A, Cardona K.Soft-tissue sarcoma in adults: an update on the current state of histiotype-specific management in an era of personalized medicine[J]. CA Cancer J Clin, 2020, 70(3):200-229. DOI: 10.3322/caac.21605. [2] Blay JY, Honoré C, Stoeckle E, et al.Surgery in reference centers improves survival of sarcoma patients: a nationwide study[J]. Ann Oncol, 2019, 30(8):1407. DOI: 10.1093/annonc/mdz170. [3] Rosenberg SA, Tepper J, Glatstein E, et al.The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy[J]. Ann Surg, 1982, 196(3):305-315. DOI: 10.1097/00000658-198209000-00009. [4] Pisters PW, Harrison LB, Leung DH, et al.Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma[J]. J Clin Oncol, 1996, 14(3):859-868. DOI: 10.1200/JCO.1996.14.3.859. [5] Yang JC, Chang AE, Baker AR, et al.Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity[J]. J Clin Oncol, 1998, 16(1):197-203. DOI: 10.1200/JCO.1998.16.1.197. [6] Alektiar KM, Brennan MF, Healey JH, et al.Impact of intensity-modulated radiation therapy on local control in primary soft-tissue sarcoma of the extremity[J]. J Clin Oncol, 2008, 26(20):3440-3444. DOI: 10.1200/JCO.2008.16.6249. [7] von Mehren M, Randall RL, Benjamin RS, et al. Soft tissue sarcoma, version 2.2018, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2018, 16(5):536-563. DOI: 10.6004/jnccn.2018.0025. [8] Haas RL, Delaney TF, O', et al. Radiotherapy for management of extremity soft tissue sarcomas: why, when, and where?[J]. Int J Radiat Oncol Biol Phys, 2012, 84(3):572-580. DOI: 10.1016/j.ijrobp.2012.01.062. [9] Salerno KE, Alektiar KM, Baldini EH, et al.Radiation therapy for treatment of soft tissue sarcoma in adults: executive summary of an ASTRO clinical practice guideline[J]. Pract Radiat Oncol, 2021, 11(5):339-351. DOI: 10.1016/j.prro.2021.04.005. [10] Dickie CI, Griffin AM, Parent AL, et al.The relationship between local recurrence and radiotherapy treatment volume for soft tissue sarcomas treated with external beam radiotherapy and function preservation surgery[J]. Int J Radiat Oncol Biol Phys, 2012, 82(4):1528-1534. DOI: 10.1016/j.ijrobp.2011.03.061. [11] Davis AM, O'Sullivan B, Turcotte R, et al. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma[J]. Radiother Oncol, 2005, 75(1):48-53. DOI: 10.1016/j.radonc.2004.12.020. [12] Guillou L, Coindre JM, Bonichon F, et al.Comparative study of the national cancer institute and french federation of cancer centers sarcoma group grading systems in a population of 410 adult patients with soft tissue sarcoma[J]. J Clin Oncol, 1997, 15(1):350-362. DOI: 10.1200/JCO.1997.15.1.350. [13] White LM, Wunder JS, Bell RS, et al.Histologic assessment of peritumoral edema in soft tissue sarcoma[J]. Int J Radiat Oncol Biol Phys, 2005, 61(5):1439-1445. DOI: 10.1016/j.ijrobp.2004.08.036. [14] O'Sullivan B, Davis AM, Turcotte R, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial[J]. Lancet, 2002, 359(9325): 2235-2241. DOI:10.1016/s0140-6736(02)09292-9. [15] Cleator SJ, Cottrill C, Harmer C.Pattern of local recurrence after conservative surgery and radiotherapy for soft tissue sarcoma[J]. Sarcoma, 2001, 5(2):83-88. DOI: 10.1155/S1357714X01000160. [16] Levay J, O'Sullivan B, Catton C, et al. Outcome and prognostic factors in soft tissue sarcoma in the adult[J]. Int J Radiat Oncol Biol Phys, 1993, 27(5): 1091-1099. DOI:10.1016/0360-3016(93)90529-5. [17] Strander H, Turesson I, Cavallin-Ståhl E.A systematic overview of radiation therapy effects in soft tissue sarcomas[J]. Acta Oncol, 2003, 42(5-6):516-531. DOI: 10.1080/02841860310014732. [18] Cheng EY, Dusenbery KE, Winters MR, et al. Soft tissue sarcomas: preoperative versus postoperative radiotherapy[J]. J Surg Oncol, 1996, 61(2):90-99. DOI:10.1002/(sici)1096-9098(199602)61:2<90::Aid-jso2>3.0.Co;2-m. [19] Gingrich AA, Bateni SB, Monjazeb AM, et al.Neoadjuvant radiotherapy is associated with r0 resection and improved survival for patients with extremity soft tissue sarcoma undergoing surgery: A national cancer database analysis[J]. Ann Surg Oncol, 2017, 24(11):3252-3263. DOI: 10.1245/s10434-017-6019-8. [20] O'Sullivan B, Griffin AM, Dickie CI, et al. Phase 2 study of preoperative image-guided intensity-modulated radiation therapy to reduce wound and combined modality morbidities in lower extremity soft tissue sarcoma[J]. Cancer, 2013, 119(10): 1878-1884. DOI:10.1002/cncr.27951. [21] Lin PP, Schupak KD, Boland PJ, et al.Pathologic femoral fracture after periosteal excision and radiation for the treatment of soft tissue sarcoma[J]. Cancer, 1998, 82(12):2356-2365. [22] Lin PP, Boland PJ, Healey JH.Treatment of femoral fractures after irradiation[J]. Clin Orthop Relat Res, 1998, (352):168-178.
2022, Vol. 31 
